CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction Level of Scientific Evidence Underlying the Current American College of Cardiology/American Heart Association Clinical Practice Guidelines Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trial Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart Disease The Prognostic Value of Exercise Echocardiography After Percutaneous Coronary Intervention Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update: A Guideline From the American Heart Association Randomized Comparison of Everolimus- and Zotarolimus-Eluting Coronary Stents With Biolimus-Eluting Stents in All-Comer Patients

Review ArticleEpub 2017 Sep 15; Volume 15, 2017 - Issue 11

JOURNAL:Expert Rev Cardiovasc Ther. Article Link

Robotics in percutaneous cardiovascular interventions

Pourdjabbar A, Ang L, Mahmud E et al. Keywords: Robotics; coronary artery disease; percutaneous coronary intervention; peripheral arterial disease; radiation safety

ABSTRACT

Introduction - The fundamental technique of performing percutaneous cardiovascular (CV) interventions has remained unchanged and requires operators to wear heavy lead aprons to minimize exposure to ionizing radiation. Robotic technology is now being utilized in interventional cardiology partially as a direct result of the increasing appreciation of the long-term occupational hazards of the field. This review was undertaken to report the clinical outcomes of percutaneous robotic coronary and peripheral vascular interventions.

Areas covered - A systematic literature review of percutaneous robotic CV interventions was undertaken. The safety and feasibility of percutaneous robotically-assisted CV interventions has been validated in simple to complex coronary disease, and iliofemoral disease. Studies have shown that robotically-assisted PCI significantly reduces operator exposure to harmful ionizing radiation without compromising procedural success or clinical efficacy. In addition to the operator benefits, robotically-assisted intervention has the potential for patient advantages by allowing more accurate lesion length measurement, precise stent placement and lower patient radiation exposure. However, further investigation is required to fully elucidate these potential benefits.

Expert commentary - Incremental improvement in robotic technology and telecommunications would enable treatment of an even broader patient population, and potentially provide remote robotic PCI.